The market slipped Friday after AI investors remembered that private-market valuations still have to survive public-market gravity. Oh, and the U.S. struck Iran after the Strait drone hit yesterday did not go over well in Washington today.

OpenAI’s possible IPO delay, SpaceX’s fade back toward its debut price, and the reversal in memory winners all pointed to the same thing: traders still want the AI story, but they are done paying blindly for every version of it.

The bid moved elsewhere. Health care led, real estate and utilities held firm, and tech lagged as money looked for places that did not require defending a near-$1T valuation or a brand-new acquisition thesis.

Stocktwits was busy picking through the wreckage: $MSTR’s Bitcoin-treasury debate, $BE’s AI-power selloff, $ON’s rejected Synaptics deal, and $IBRX’s Russell-index squeeze setup got the loudest reads.

Today's Briefing:

OpenAI may push its IPO into 2027 according to rumors from the NY Times Friday, and the AI trade suddenly remembered that private-market valuations do not come with a money-back guarantee. The ChatGPT maker is reportedly weighing whether to list below a $1T valuation this year or wait for calmer tech markets after SpaceX and Cerebras gave investors a fresh reminder that IPO hype can, in fact, go down.

The RIP: OpenAI was valued at $852B in its last private round. SoftBank’s planned OpenAI exposure is expected to reach roughly $65B by October, and its shares fell 13% on the delay report. SpaceX traded above $225 after debuting at $150, then fell back near $151.

The problem is not that OpenAI suddenly stopped being important. It is that public investors are starting to ask the rude questions: how much cash gets burned, how durable the growth is, and whether competition from SpaceX’s xAI, Anthropic, Google, and everyone else with a server budget makes a near-$1T valuation a little rich.

For retail traders, the clean public read-through is in the proxy basket. There is a Stocktwits board for OpenAI already, but it is not well traveled, the ticker is a strange private market ticker, as the firm has not announced a real ticker to sell. OpenAI needs a target date before it gets to choose a ticker. There are public stocks affected:

$MSFT has the OpenAI exposure, $SFTBY has the SoftBank mark-to-market problem, $SPCX is the IPO cautionary tale, and $NVDA still sells the shovels if the AI buildout keeps going. Next week’s IPO calendar matters too, because if deals like Bending Spoons, Lime, CopperTech, and ITG price cleanly, OpenAI’s delay looks company-specific. If they wobble, the unicorn parade may need a water break.

Take it to $MSFT: AI kingmaker or capex hostage? →

1.2 million works worth around $100 billion. All locked away by collectors with no intention of exhibiting them. More art sits in the Geneva Freeport than in the Louvre. 

The reason? It's the world's largest tax-free vault. Works are traded inside without ever crossing a border or appearing in any public record.

When that much inventory is effectively off the table, anytime something does circulate, it’s a rare occasion.

Just a three hour drive away, the world’s premier international art fair is one of those occasions. Art Basel is this month and needless to say, things will move fast. Serious collectors will make their transactions before doors even open to the wider public.

Masterworks' acquisition committee — former specialists from Sotheby's and Christie's — operate in that window. Purchased artworks here can even become the offerings that Masterworks members fractionally invest in. 

Their track record to-date?

Skip the waitlist to become a member.

^{Investing involves risk. Past performance is not indicative of future returns. See important Reg A disclosures at masterworks.com/cd.}

*3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.

ON Semiconductor cratered Friday after the auto and industrial chipmaker agreed to buy Synaptics in a roughly $7B all-stock deal. The strategic pitch is edge AI and “physical AI,” but the tape heard dilution, integration risk, and a harder-to-underwrite pivot away from the cleaner data-center story.

The RIP: $ON ( ▼ 23.66% ) fell 23.7% to $90.65, while $SYNA ( ▼ 3.68% ) slipped 3.7% to $121. Synaptics holders will receive 1.35 onsemi shares per share, a 19% premium, and own roughly 12% of the combined company. Onsemi expects $200M in annual synergies and closing by mid-2027.

The deal could expand onsemi’s reach into robotics, autonomous systems, sensing, and connected compute, but investors clearly hated the structure. All-stock M&A works best when shareholders believe the buyer is using expensive paper. Friday’s reaction said Wall Street was not thrilled about paying up for a longer-term AI story while taking dilution now.

Community is bearish, message volume is high.

Make your case in $ON: edge-AI bargain or dilution trap? →

ImmunityBio jumped Friday as retail traders circled the cancer immunotherapy developer around Russell 1000 inclusion speculation, options activity, and another round of short-squeeze chatter. The move was more index-flow and positioning story than clean fundamental news, but that has never stopped biotech traders from making it loud.

The RIP: $IBRX ( ▲ 11.81% ) rose 11.8% to $8.71. The stock traded as high as $8.85, with volume above 40.9M shares. FTSE Russell’s 2026 reconstitution takes effect after Friday’s close, and the large-cap/small-cap breakpoint rose to $5.7B.

The useful read is that $IBRX has become a tug-of-war between forced-flow bulls and valuation skeptics. Index inclusion can create mechanical demand, but it does not change the core question: whether ImmunityBio can turn Anktiva momentum and pipeline optionality into revenue and profit big enough to justify the run.

Community is neutral, message volume is normal.

Drop your take in $IBRX: index flow or fundamentals next? →

Money bailed on tech this week, but it did not leave the market. It hid in health care, utilities, real estate, and anything that did not need a trillion-dollar AI valuation to make sense.

$XLK ( ▼ 1.88% ) Technology -5.3%: Tech was the weekly drag, with $QQQ down -4.4% even as $IWM and $DIA finished green. This was not “AI is dead.” It was traders getting pickier: $MU proved memory suppliers have pricing power, while $AAPL and $MSFT showed the companies buying those chips now have a margin and pricing problem.

$XLV ( ▲ 3.03% ) Health Care +6.6%: Health care was the week’s cleanest hiding place. The group finished Friday up +3.0%, helped by defensive flow, biotech strength, and legal-overhang relief after Bayer’s Roundup win. When tech stops acting like a one-way ATM, boring suddenly gets a fan club.

$XLRE ( ▲ 1.46% ) Real Estate +2.9% and $XLU Utilities +3.1%: The rate-sensitive stuff caught money even after hot PCE, mostly because crude got smoked. WTI fell -8.9% on the week and -2.2% Friday, easing some headline inflation pressure and giving bond-proxy sectors a reason to breathe while core inflation stayed sticky.

$XLI ( ▼ 1.59% ) Industrials +0.3%: Industrials barely moved on the week, but that was the point. The group held up while tech sold off, even after falling -1.6% Friday. With $DIA up +0.5% for the week and $SPY down -2.0%, the old-economy tape did its job while the AI trade got stress-tested.

$XLY ( ▲ 0.9% ) Consumer Discretionary -2.4% and $XLC Communication Services -2.7%: The consumer and platform side of the market took the AI bill harder. $AAPL rebounded +2.1% Friday after Thursday’s MacBook and iPad price-hike drop, while $MSFT bounced +5.5% after capex and component-cost worries. $SPCX hovered near $152 after trading above $225 post-debut, giving private-market AI and space valuations a public-market slap.

Watch into next week: The test is whether tech can broaden beyond the memory suppliers. $MU fell -5.4% Friday and $SNDK dropped -9.4%, while $AAPL and $MSFT rebounded. If that handoff holds, the AI trade gets healthier. If $SPCX keeps leaking and software multiples stay heavy, this week was not a dip, it was the market asking for receipts.

$LCID ( ▲ 15.63% ) Lucid ⚡: jumped +13% after robotaxi partnerships revived turnaround hopes

$QCOM ( ▼ 7.57% ) Qualcomm: fell -8% after OpenAI IPO fears hit AI suppliers

$SNDK ( ▼ 10.46% ) Sandisk: dropped -10% after memory winners gave back gains

$CAPR ( ▼ 13.03% ) Capricor ⚡: dropped -12% after FDA panel timing sparked volatility

$STX ( ▼ 12.24% ) Seagate: tumbled -12% after storage stocks cooled from Micron rally

$WDC ( ▼ 13.17% ) Western Digital: tumbled -13% after memory-stock profit taking accelerated

$BE ( ▼ 18.49% ) Bloom Energy ⚡: cratered -17% after data-center pause hit AI-power bulls

📈 U.S. strikes Iran after Trump accuses Tehran of ceasefire violation in Strait of Hormuz

😨 Corporate profits were already at historic highs. They shot even higher in Q1.

🏠 Oracle stock has worst week since 2001 dot-com bust as AI financing concerns escalate

💰 Volkswagen job cuts: 100,000 jobs and 4 plant closures planned

📺 Minneapolis Fed President Neel Kashkari says he expects a rate hike this year

Want to see some change? Email Kevin Travers feedback, or Follow him on Stocktwits.